Development of a new serological assay for the diagnosis of Clostridium difficile infections with prognostic value

ConclusionsIt has already been observed that low antibody levels are associated with recurrent CDI (Bauer et al., 2014). The findings of our clinical trial show a similar trend. Our developed ELISA test could help to conduct further research and it might be helpful in clinical use to detect patients of high risk for CDI recurrence.
Source: Journal of Microbiological Methods - Category: Microbiology Source Type: research